Correlation Between Novo Nordisk and Bionomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Bionomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Bionomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Bionomics Limited, you can compare the effects of market volatilities on Novo Nordisk and Bionomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Bionomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Bionomics.

Diversification Opportunities for Novo Nordisk and Bionomics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Novo and Bionomics is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Bionomics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionomics Limited and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Bionomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionomics Limited has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Bionomics go up and down completely randomly.

Pair Corralation between Novo Nordisk and Bionomics

Assuming the 90 days horizon Novo Nordisk is expected to generate 47.6 times less return on investment than Bionomics. But when comparing it to its historical volatility, Novo Nordisk AS is 17.85 times less risky than Bionomics. It trades about 0.05 of its potential returns per unit of risk. Bionomics Limited is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1.27  in Bionomics Limited on September 1, 2024 and sell it today you would earn a total of  0.04  from holding Bionomics Limited or generate 3.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy24.84%
ValuesDaily Returns

Novo Nordisk AS  vs.  Bionomics Limited

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Bionomics Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionomics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Bionomics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Novo Nordisk and Bionomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Bionomics

The main advantage of trading using opposite Novo Nordisk and Bionomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Bionomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will offset losses from the drop in Bionomics' long position.
The idea behind Novo Nordisk AS and Bionomics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories